nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxacurium chloride—CHRND—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA4—attention deficit hyperactivity disorder	0.0543	0.0664	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0378	0.0462	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0359	0.0439	CbGpPWpGaD
Doxacurium chloride—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0353	0.0432	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Effects of Botulinum toxin—SNAP25—attention deficit hyperactivity disorder	0.0351	0.0429	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0322	0.0393	CbGpPWpGaD
Doxacurium chloride—CHRND—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0312	0.0381	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0306	0.0374	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.03	0.0367	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA4—attention deficit hyperactivity disorder	0.0285	0.0349	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0265	0.0324	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA4—attention deficit hyperactivity disorder	0.0252	0.0308	CbGpPWpGaD
Doxacurium chloride—CHRND—cardiovascular system—attention deficit hyperactivity disorder	0.0224	0.123	CbGeAlD
Doxacurium chloride—CHRNA2—forebrain—attention deficit hyperactivity disorder	0.0183	0.1	CbGeAlD
Doxacurium chloride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—attention deficit hyperactivity disorder	0.018	0.022	CbGpPWpGaD
Doxacurium chloride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.0153	0.0187	CbGpPWpGaD
Doxacurium chloride—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.0152	0.0186	CbGpPWpGaD
Doxacurium chloride—CHRNB1—midbrain—attention deficit hyperactivity disorder	0.0113	0.0617	CbGeAlD
Doxacurium chloride—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.0112	0.0137	CbGpPWpGaD
Doxacurium chloride—CHRM2—forebrain—attention deficit hyperactivity disorder	0.0109	0.0599	CbGeAlD
Doxacurium chloride—CHRNA2—nervous system—attention deficit hyperactivity disorder	0.00994	0.0545	CbGeAlD
Doxacurium chloride—CHRNA2—central nervous system—attention deficit hyperactivity disorder	0.00957	0.0525	CbGeAlD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00955	0.0117	CbGpPWpGaD
Doxacurium chloride—CHRNA2—cerebellum—attention deficit hyperactivity disorder	0.00936	0.0513	CbGeAlD
Doxacurium chloride—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00924	0.0507	CbGeAlD
Doxacurium chloride—CHRNA1—brain—attention deficit hyperactivity disorder	0.00916	0.0502	CbGeAlD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00907	0.0111	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.00898	0.011	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0088	0.0108	CbGpPWpGaD
Doxacurium chloride—CHRNB1—cerebellum—attention deficit hyperactivity disorder	0.00871	0.0478	CbGeAlD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00844	0.0103	CbGpPWpGaD
Doxacurium chloride—CHRNA2—brain—attention deficit hyperactivity disorder	0.0076	0.0417	CbGeAlD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.00755	0.00923	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0074	0.00905	CbGpPWpGaD
Doxacurium chloride—BCHE—forebrain—attention deficit hyperactivity disorder	0.00726	0.0398	CbGeAlD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00718	0.00878	CbGpPWpGaD
Doxacurium chloride—CHRNB1—brain—attention deficit hyperactivity disorder	0.00707	0.0388	CbGeAlD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00682	0.00834	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00647	0.00791	CbGpPWpGaD
Doxacurium chloride—BCHE—cardiovascular system—attention deficit hyperactivity disorder	0.00614	0.0337	CbGeAlD
Doxacurium chloride—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00593	0.0325	CbGeAlD
Doxacurium chloride—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00571	0.0313	CbGeAlD
Doxacurium chloride—CHRNA1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.0055	0.00673	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.00533	0.00652	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00523	0.00639	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.00513	0.00627	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.00496	0.00606	CbGpPWpGaD
Doxacurium chloride—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00494	0.00605	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0048	0.00587	CbGpPWpGaD
Doxacurium chloride—BCHE—midbrain—attention deficit hyperactivity disorder	0.0048	0.0263	CbGeAlD
Doxacurium chloride—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.00472	0.00577	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.00466	0.0057	CbGpPWpGaD
Doxacurium chloride—CHRM2—brain—attention deficit hyperactivity disorder	0.00453	0.0249	CbGeAlD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.00448	0.00548	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.00434	0.00531	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00432	0.00529	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.0042	0.00514	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.00417	0.0051	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.00404	0.00494	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00399	0.00488	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.00397	0.00485	CbGpPWpGaD
Doxacurium chloride—BCHE—nervous system—attention deficit hyperactivity disorder	0.00394	0.0216	CbGeAlD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.00392	0.00479	CbGpPWpGaD
Doxacurium chloride—BCHE—central nervous system—attention deficit hyperactivity disorder	0.0038	0.0208	CbGeAlD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00376	0.0046	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00372	0.00455	CbGpPWpGaD
Doxacurium chloride—BCHE—cerebellum—attention deficit hyperactivity disorder	0.00371	0.0203	CbGeAlD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00367	0.00449	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.00365	0.00446	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00349	0.00427	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00346	0.00423	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00331	0.00405	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00316	0.00386	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00308	0.00377	CbGpPWpGaD
Doxacurium chloride—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00304	0.00372	CbGpPWpGaD
Doxacurium chloride—BCHE—brain—attention deficit hyperactivity disorder	0.00301	0.0165	CbGeAlD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.003	0.00367	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00294	0.00359	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00288	0.00353	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00285	0.00348	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00282	0.00344	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00279	0.00341	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00279	0.00341	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00267	0.00327	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00265	0.00324	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00262	0.0032	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00262	0.0032	CbGpPWpGaD
Doxacurium chloride—CHRND—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0026	0.00318	CbGpPWpGaD
Doxacurium chloride—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00256	0.00313	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00249	0.00304	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00242	0.00296	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00236	0.00289	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0023	0.00281	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00225	0.00275	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00223	0.00272	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00221	0.0027	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00214	0.00262	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00213	0.00261	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00212	0.00259	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0021	0.00257	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00207	0.00253	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00201	0.00245	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00201	0.00245	CbGpPWpGaD
Doxacurium chloride—CHRND—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00199	0.00244	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00193	0.00236	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00191	0.00233	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00187	0.00228	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00179	0.00219	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00173	0.00212	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00171	0.00209	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0017	0.00208	CbGpPWpGaD
Doxacurium chloride—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.0017	0.00208	CbGpPWpGaD
Doxacurium chloride—CHRNA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00169	0.00207	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00169	0.00206	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00166	0.00203	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00162	0.00198	CbGpPWpGaD
Doxacurium chloride—CHRNA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00161	0.00197	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00154	0.00188	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00154	0.00188	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00149	0.00182	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00148	0.00181	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00146	0.00178	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00143	0.00175	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00143	0.00175	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00137	0.00168	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00135	0.00165	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00127	0.00155	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00127	0.00155	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00118	0.00144	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00118	0.00144	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00117	0.00143	CbGpPWpGaD
Doxacurium chloride—BCHE—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00116	0.00142	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00113	0.00138	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00136	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00111	0.00136	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00108	0.00132	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00105	0.00129	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00104	0.00127	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00126	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00101	0.00123	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.000998	0.00122	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.000981	0.0012	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.000969	0.00119	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.000957	0.00117	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.000953	0.00117	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.000926	0.00113	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.000911	0.00111	CbGpPWpGaD
Doxacurium chloride—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.000903	0.0011	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.000899	0.0011	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000894	0.00109	CbGpPWpGaD
Doxacurium chloride—BCHE—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000888	0.00109	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000882	0.00108	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000878	0.00107	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000865	0.00106	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000838	0.00102	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00082	0.001	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000794	0.000971	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00078	0.000954	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000771	0.000942	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000768	0.000939	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000718	0.000878	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000671	0.000821	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000639	0.000782	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000626	0.000766	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000624	0.000763	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000604	0.000739	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000594	0.000727	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000587	0.000718	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000587	0.000718	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00058	0.00071	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000569	0.000695	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000547	0.000669	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000539	0.000659	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000511	0.000625	CbGpPWpGaD
Doxacurium chloride—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000503	0.000615	CbGpPWpGaD
Doxacurium chloride—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000465	0.000569	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000434	0.000531	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000399	0.000488	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000394	0.000482	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000383	0.000468	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000379	0.000464	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000372	0.000455	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000372	0.000455	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000366	0.000447	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000353	0.000431	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000345	0.000421	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000343	0.000419	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000342	0.000418	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00034	0.000416	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000336	0.000411	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000336	0.000411	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000332	0.000406	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000329	0.000403	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00032	0.000392	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00031	0.000379	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000309	0.000378	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000305	0.000373	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000301	0.000368	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000297	0.000363	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000283	0.000346	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000281	0.000343	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000233	0.000285	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—COMT—attention deficit hyperactivity disorder	0.000225	0.000275	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000224	0.000273	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000217	0.000265	CbGpPWpGaD
Doxacurium chloride—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000216	0.000265	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000204	0.000249	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000196	0.00024	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000189	0.000231	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000183	0.000224	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00018	0.00022	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000178	0.000218	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000166	0.000203	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000116	0.000142	CbGpPWpGaD
Doxacurium chloride—BCHE—Metabolism—EP300—attention deficit hyperactivity disorder	9.66e-05	0.000118	CbGpPWpGaD
Doxacurium chloride—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.15e-05	7.52e-05	CbGpPWpGaD
